Top Markets
Coin of the day
Apexigen, Inc. Apexigen, Inc.

Apexigen, Inc.

APGN
Classement en actions #36265
Apexigen Inc., established in 2010 and based in San Carlos, California, is a... Apexigen Inc., established in 2010 and based in San Carlos, California, is a clinical-stage biotechnology company dedicated to the discovery and advancement of antibody-based therapies for oncological diseases. The company's developmental pipeline features several promising candidates. A primary focus is APX005M, a humanized agonist antibody currently in Phase II clinical trials. This therapeutic agent is being explored for its efficacy against a variety of solid tumors, including melanoma, esophageal and gastroesophageal junction cancers, sarcoma, and rectal and ovarian malignancies, often in conjunction with other established treatments like immunotherapy, chemotherapy, radiation therapy, and cancer vaccines. Additionally, Apexigen is progressing APX601, a humanized antagonist antibody, through Phase I/II clinical trials for numerous tumor indications. Rounding out their experimental portfolio is APX801, an NK cell engager engineered to stimulate natural killer cells to eradicate cancerous cells.
Prix de l'action
$0.385
Dernière synchronisation: 2023-09-01
Capitalisation boursière
$2.86M
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Apexigen, Inc. (APGN)

Catégorie

Historique du prix de l'action pour Apexigen, Inc. (APGN)
Prix de clôture le plus élevé : $0.39 le 2023-09-01

Prix de clôture le plus bas : $10.40 le 2021-02-01
Historique du prix de l'action de Apexigen, Inc. de 2021 à 2026
Performance annuelle du prix de l'action
Année Performance
2023 -63.18%
2022 -89.52%
2021 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE